Importance COVID-19 is associated with clinically significant symptoms despite resolution of
the acute infection (ie, post-COVID-19 syndrome). Fatigue and cognitive impairment are …

I. Executive Summary Background The 5 years since the publication of the first International
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …

Altered olfactory function is a common symptom of COVID-19, but its etiology is unknown. A
key question is whether SARS-CoV-2 (CoV-2)–the causal agent in COVID-19–affects …

The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2),
was first identified in December of 2019 in the city of Wuhan, China. Since the outbreak …

The main neurological manifestation of COVID-19 is loss of smell or taste. The high
incidence of smell loss without significant rhinorrhea or nasal congestion suggests that …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has currently infected over 6.5 million people worldwide. In …

The emergence of SARS-CoV-2 has created an international health crisis, and small animal
models mirroring SARS-CoV-2 human disease are essential for medical countermeasure …

Abstract Background For some SARS-CoV-2 survivors, recovery from the acute phase of the
infection has been grueling with lingering effects. Many of the symptoms characterized as …

The occurrence of anosmia, the loss or change in sense of smell, is one of the most common
symptoms of COVID-19 experienced by almost 53% of those affected. Several hypotheses …

Introduction: Loss of smell and taste is now recognised as amongst the most common
symptoms of COVID-19 and the best predictor of COVID-19 positivity. Long term outcomes …